terminal cancer - Nursing Case Study
Pathophysiology
• Primary mechanism: Uncontrolled cellular proliferation - Terminal cancer is characterized by the relentless growth of malignant cells due to genetic mutations that override normal regulatory processes, leading to tumor expansion and metastasis.
• Secondary mechanism: Angiogenesis - Cancer cells stimulate the formation of new blood vessels to supply the growing tumor with nutrients and oxygen, facilitating further growth and the potential for metastatic spread to distant organs.
• Key complication: Organ dysfunction - As tumors grow and metastasize, they can invade and disrupt the function of vital organs, leading to systemic failure. This, combined with the body's inflammatory response to cancer, often results in significant clinical decline and is a major cause of mortality in terminal cancer patients.
Patient Profile
Demographics:
58-year-old female, retired school teacher
History:
• Key past medical history: Diagnosed with metastatic breast cancer two years ago, hypertension, type 2 diabetes
• Current medications: Paclitaxel, Lisinopril, Metformin, Insulin, Ondansetron for nausea
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increasing abdominal pain and fatigue
• Key symptoms: Unintentional weight loss, persistent cough, nausea, occasional confusion
• Vital signs: Blood pressure 145/90 mmHg, heart rate 110 bpm, respiratory rate 22 breaths per minute, temperature 99.1°F, oxygen saturation 92% on room air
Section 1
New Diagnostic Results:
Following the patient's recent presentation of increasing abdominal pain, fatigue, persistent cough, and occasional confusion, a thorough diagnostic workup was initiated to assess the progression of her metastatic breast cancer and evaluate potential complications. A CT scan of the abdomen and chest revealed significant findings. The imaging showed a marked increase in the size of hepatic metastases, with several lesions now demonstrating central necrosis. Additionally, there was evidence of moderate ascites, likely contributing to her abdominal discomfort and distension. The chest CT also indicated progression of pulmonary metastases, with new lesions in the right middle and lower lobes, correlating with her persistent cough and reduced oxygen saturation.
Laboratory results further elucidated the patient's condition. Her liver function tests showed elevated bilirubin and alkaline phosphatase levels, suggesting impaired hepatic function due to extensive liver involvement. Additionally, a mild elevation in serum creatinine was noted, raising concerns about potential renal impairment, which could be secondary to dehydration from ongoing nausea or possible metastatic involvement. Blood glucose levels were erratic, indicating challenges in managing her diabetes amid the stress of her advancing cancer and potential liver dysfunction impacting gluconeogenesis.
These diagnostic findings underscore the complexity of her condition, highlighting the need for comprehensive management to address both the direct effects of tumor progression and the secondary impacts on organ systems. The healthcare team must now deliberate on strategies to alleviate symptoms and improve quality of life, while considering the limitations and potential side effects of further oncologic treatments in the context of her declining organ function. This situation presents an opportunity for clinical reasoning on palliative interventions, medication adjustments, and supportive care measures to address her multifaceted needs.
Section 2
Change in Patient Status:
In the days following the updated diagnostic results, the patient's clinical status has noticeably fluctuated, prompting the healthcare team to reassess her management plan. The patient has experienced increased episodes of confusion and lethargy, likely exacerbated by her worsening hepatic encephalopathy due to the elevated bilirubin levels and impaired liver function. Her vital signs reveal a blood pressure of 95/60 mmHg, heart rate of 110 beats per minute, and a respiratory rate of 24 breaths per minute, indicating a compensatory response to potential hypovolemia and hypoxia. Oxygen saturation remains borderline, hovering around 88% on room air, requiring supplemental oxygen to maintain adequate levels.
Clinically, the patient is exhibiting signs of worsening ascites, with her abdominal girth increasing by 4 cm since the last assessment, contributing to her discomfort and impacting her breathing. The irregular blood glucose levels persist, with frequent hypoglycemic episodes despite adjustments in her insulin regimen, suggesting a need for closer monitoring and possible alterations in her diabetic management. Additionally, the slight rise in serum creatinine to 1.6 mg/dL suggests a potential prerenal cause, possibly due to reduced oral intake and dehydration from persistent nausea and vomiting.
These changes in her clinical status necessitate a multidisciplinary approach to refine her care plan. The team must consider optimizing her fluid balance to address dehydration without exacerbating her ascites, potentially through cautious use of diuretics or paracentesis if indicated. Furthermore, the management of her hepatic encephalopathy through lactulose or rifaximin adjustment and frequent blood glucose monitoring is crucial to stabilizing her condition. These considerations are pivotal in ensuring that the patient's symptoms are managed effectively, paving the way for discussions on advanced care planning and aligning treatment goals with her quality of life priorities.
Section 3
As the multidisciplinary team convenes to address the patient's ongoing complications, her response to interventions provides both insights and challenges. Following the cautious administration of intravenous fluids and an adjusted diuretic regimen aimed at alleviating her dehydration without worsening her ascites, there is a slight improvement in her blood pressure, now reading at 100/65 mmHg. However, her heart rate remains elevated at 108 beats per minute, indicating persistent compensatory mechanisms or possibly underlying pain or anxiety. Despite the fluid adjustments, her abdominal discomfort continues, and her ascites has shown no significant reduction, suggesting the need for further intervention, potentially through paracentesis, to relieve symptoms and improve respiratory function.
In terms of managing her hepatic encephalopathy, the adjustment in lactulose dosage appears to have yielded a modest improvement in her mental status. She exhibits fewer episodes of confusion, although lethargy persists, likely compounded by her overall debilitated state. Her oxygen saturation has stabilized around 92% with supplemental oxygen, showing some improvement yet still requiring vigilant monitoring. Meanwhile, her glycemic control remains erratic, with recurrent hypoglycemic episodes despite close monitoring and insulin regimen adjustments. This suggests that her nutritional intake needs reassessment, as poor oral intake due to nausea and vomiting could be a contributing factor to her unstable glucose levels.
The latest laboratory results reveal a concerning upward trend in her liver enzymes and bilirubin levels, indicating further hepatic deterioration. Her albumin level has decreased to 2.8 g/dL, hinting at worsening synthetic liver function and contributing to her ascites. The slightly elevated serum creatinine remains stable, suggesting that while renal function is a concern, it has not yet progressed to acute kidney injury. These findings underscore the complexity of her condition, demanding ongoing coordination among the healthcare team to balance the management of her multifaceted symptoms. This new information paves the way for revisiting her care goals, focusing on palliative measures that prioritize her comfort and quality of life.
Section 4
As the healthcare team continues to monitor the patient closely, a new complication emerges, further complicating her clinical picture. During a routine assessment, the patient begins exhibiting signs of respiratory distress; her respiratory rate has increased to 28 breaths per minute, and she appears visibly uncomfortable with labored breathing. Auscultation reveals diminished breath sounds at the bases and fine crackles, suggestive of pleural effusions or fluid overload due to her persistent ascites. Her oxygen saturation has dropped to 88% despite the use of supplemental oxygen, prompting immediate concern and the need for intervention to prevent further respiratory compromise.
In light of these developments, the team considers the necessity of a paracentesis to alleviate the pressure from her ascites, which may be contributing to her respiratory issues. The procedure is anticipated to not only provide symptomatic relief but also potentially improve her oxygenation status. Concurrently, a chest X-ray is ordered to evaluate the presence and extent of any pleural effusions, as well as to rule out other causes of her respiratory decline, such as pneumonia or atelectasis. The interdisciplinary team, including the palliative care specialists, revisits her advance directives and care goals with the patient and her family, ensuring that all interventions align with her wishes for comfort-focused care.
This change in her condition necessitates careful clinical reasoning and coordination among the healthcare team to prioritize interventions that address her immediate respiratory needs while managing her complex, interrelated symptoms. The team must balance the risks and benefits of invasive procedures like paracentesis against her overall prognosis and quality of life, ensuring that each decision supports her palliative care objectives. This evolving scenario highlights the need for proactive and compassionate communication, as well as a flexible approach to care planning that adapts to the patient's changing status and priorities.
Section 5
The healthcare team proceeds with a paracentesis in an effort to relieve the pressure from the patient’s ascites, which is suspected to be contributing to her respiratory distress. Following the procedure, the patient's respiratory rate decreases to 22 breaths per minute, and she reports a subjective sense of improved breathing. Her oxygen saturation marginally improves to 91% with supplemental oxygen support, indicating a partial relief of her respiratory compromise. However, the team remains vigilant for any potential complications from the procedure, such as hypotension or infection, given her fragile state.
Meanwhile, the results of the chest X-ray return, revealing moderate bilateral pleural effusions. This finding corroborates the earlier auscultatory findings and suggests that additional intervention may be necessary to further optimize her respiratory function. The team discusses the possibility of a therapeutic thoracentesis to drain the pleural effusions, weighing the potential benefits against the risks in her current condition. Her lab results also show a slight decrease in her hemoglobin and hematocrit levels, which could be indicative of either blood loss or hemodilution, adding another layer of complexity to her management.
As the team considers these diagnostic insights, they engage in a thorough discussion with the patient and her family about the next steps. Emphasizing the goals of care that prioritize comfort and quality of life, the team ensures that the proposed interventions align with her palliative care plan. The family expresses their desire to prioritize measures that will enhance her comfort without aggressive interventions, reinforcing the need for ongoing, sensitive communication. This situation underscores the importance of integrating clinical findings with patient-centered care, as the team navigates the delicate balance of addressing acute clinical needs while respecting the patient’s end-of-life wishes.